Events: After Orlando page 2

The Lost Cancer Serum - Events 1

The Lost Cancer Serum - EVENTS 2

DR. CONNELL'S IDEOLOGY OF PROVIDING HEALTH CARE AT A LOW COST WAS IN CONFLICT WITH THE SUCCESS OF OTHERS.

It seemed that the $20 price that Dr. Connell wanted the consumer to pay was too low and that no distribution company could cover their costs.

The $20 price tag was provided with permission from the Federal Department of Health in March 1946 when the Hendry Connell Research Foundation was granted a license to manufacture and sell Ensol.

EVENTS: 1 2

After Orlando

Even after the Orlando tragedy, interest was still very high for Ensol, not only from individual doctors and patients but also from, no less than six pharmaceutical companies, including one, which Dr. Connell established, himself called Co-Drug Ltd. which also distributed drugs for other companies.

Smallwood Pharmaceuticals Ltd. of Orangeville Ontario appears to be the first company to sign an agreement in 1945. However, the foundation soon canceled it

and Smallwood returned 5000 vials in early May 1946. This agreement was short lived and there is no record of the reason for this abrupt cancellation, but it is assumed that the normal discount of 40% due to a distributing agency deducted from the twenty-dollar price set by the foundation did not nearly cover the cost of production.

The $20 price tag was provided with permission from the Federal Department of Health in March 1946 when the Hendry Connell Research Foundation was granted a license to manufacture and sell Ensol. Up to this time, Ensol could not be sold legally but was offered at no charge. Ensol was now passing all government principally, sterility and non-pyrogenic tests that were required to keep the license.

One off shore distributor

named Felix N. Rodriguez of
the Dominican Republic also received 100 vial samples in August 1948. Again, no further records exist between the foundation and Felix Rodriguez.

The J.F. Hartz Company of Toronto also started out with a distribution contract with the foundation but soon ran into the same problem as the Smallwood Company did... distribution costs were too high to substantiate the low suggested retail cost. It
seemed that the $20 price that

Dr. Connell wanted the consumer to pay was too low and that no distribution company could cover their costs. Dr. Connell’s ideology of providing health care at a low cost was in conflict with the commercial success of others.

The last recorded attempt to continue production of Ensol was with Baxter Laboratories of Chicago, Illinois in 1951. The agreement between the Foundation and Baxter was that Connell and Dr. Lloyd Munroe were to be paid consultants with Ensol being produced in Chicago under the name U-10. Baxter sent a Dr. RM. Petersen to Kingston
for two years of training on the production of Ensol. Petersen

returned to Chicago but soon after became ill and was confined to an institution never to return to work again. Through all this time Dr. Connell was sending all referrals for Ensol to Baxter letting Baxter determine the cost and selling price of the now U-10 product.

By the later 1950’s communication all but stopped between Baxter and the Connell Foundation. Even though the demand for U-10 was large and expanding from the Foundations point of view it might not have been from Baxter’s. It is not known why but Baxter destroyed and stopped production of U-10 by the late 1950’s. No reasons were given, although again, even health care companies must make a profit and it is suspected that there was no profit to be made.